Clinical Trial
Accepted on 29 Sep 2025
Targeting Cardiovascular and Metabolic Risk Modification in End Stage Renal Disease (ESRD): A Randomized Controlled Clinical Trial on Niacin's Effects on Lipoprotein(a) and Biochemical Markers in Hemodialysis Patients
in Nephrology
- 141 views